テネシーにおける心血管疾患の臨床試験
テネシー内の拠点で、心血管疾患に関する27件の研究が参加者を募集しています。
テネシー内の都市
公式研究テキスト（英語）
ELEVATE-HFpEF Clinical Study
- Saint Thomas Research Institute, Nashville
被験者募集中
40歳以上 · 全性別 · 2026/10/02更新 · NCT06678841Improving Veteran Referral to Cardiac Rehabilitation
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
被験者募集中
18歳以上 · 全性別 · 2026/10/01更新 · NCT07079358EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Alliance for Multispecialty Research, LLC-Knoxville-69693, Knoxville
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07064473Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- Stern Cardiovascular Center, Germantown
- Ballad Health System, Greeneville
- Apex Research Foundation, LLC, Jackson
- 他2件
被験者募集中第4相
18歳以上 · 全性別 · 2026/09/28更新 · NCT06909565Product Surveillance Registry
- Germantown
- Memphis
- Nashville
被験者募集中観察研究
全年齢 · 全性別 · 2026/09/18更新 · NCT01524276Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- Clinical Trial Site, Chattanooga
- Clinical Trial Site, Chattanooga
- Clinical Trial Site, Knoxville
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/18更新 · NCT07181109Zenith® Fenestrated+ Clinical Study
- Holston Valley Hospital, Kingsport
被験者募集中
18歳以上 · 全性別 · 2026/09/17更新 · NCT04875429Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
- Vanderbilt University Medical Center, Nashville
被験者募集中
18歳以上 · 全性別 · 2026/09/15更新 · NCT03242642Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
- Baptist - Memphis (Stern), Memphis
被験者募集中
18歳〜100歳 · 全性別 · 2026/09/09更新 · NCT06310031An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- The Stern Cardiovascular Foundation, Germantown
- Apex Cardiology Research Associates of Jackson, Jackson
- Vanderbilt Univ Medi Cen, Nashville
- 他1件
被験者募集中第3相
18歳〜100歳 · 全性別 · 2026/09/04更新 · NCT07517263Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)
- Vanderbilt University Medical Center, Nashville
被験者募集中
18歳〜85歳 · 全性別 · 2026/09/03更新 · NCT06703489Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
- Meharry Medical College, Nashville
- Nashville VA Medical Center, Nashville
- Vanderbilt University Medical Center, Nashville
被験者募集中第4相健康なボランティア歓迎
75歳以上 · 全性別 · 2026/09/01更新 · NCT04262206Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
- Vanderbilt University Medical Center, Nashville
被験者募集中第2相
18歳〜89歳 · 全性別 · 2026/08/27更新 · NCT05288790A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
- East Tennessee Childrens Hospital, Knoxville
被験者募集中観察研究
7歳以上 · 全性別 · 2026/08/25更新 · NCT05705531A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Chattanooga
- Research Site, Chattanooga
- Research Site, Greeneville
- 他9件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/24更新 · NCT07000357OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Erlanger Health, Inc., Chattanooga
- Ascension Saint Thomas, Nashville
- Parkway Cardiology Associates, Oak Ridge
- 他1件
被験者募集中第3相
50歳〜105歳 · 全性別 · 2026/08/21更新 · NCT07136012Global Paradise System US Post Approval Study
- Ascension Saint Thomas, Nashville
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/12更新 · NCT06297291Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
- Novartis Investigative Site, Tullahoma
被験者募集中第3相
18歳〜80歳 · 全性別 · 2026/08/07更新 · NCT06813911PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- Vanderbilt, Nashville
被験者募集中
18歳以上 · 全性別 · 2026/06/29更新 · NCT05934487Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- The Stern Cardiovascular Foundation, Memphis
被験者募集中
18歳以上 · 全性別 · 2026/06/10更新 · NCT06526195GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV
- Vanderbilt University Medical Center, Nashville
被験者募集中第2相
18歳〜89歳 · 全性別 · 2026/05/26更新 · NCT07221214Pivotal Study for the Cardiac Performance System (CPS)
- The Stern Cardiovascular Foundation, Inc. / Baptist Memorial Hospital, Germantown
被験者募集中観察研究
18歳以上 · 全性別 · 2026/04/24更新 · NCT06870591The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- Centennial Medical Center, Nashville
被験者募集中
18歳以上 · 全性別 · 2026/04/13更新 · NCT03142152Randomized Trial of SGLT2i in Heart Transplant Recipients
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
被験者募集中第4相
18歳以上 · 全性別 · 2026/01/22更新 · NCT06625073Gut Microbiota in Metabolic Surgery
- Vanderbilt_University MC, Nashville
被験者募集中観察研究
21歳〜65歳 · 全性別 · 2025/11/04更新 · NCT05000996MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
- Centennial Medical Center, Nashville
被験者募集中
18歳〜110歳 · 全性別 · 2025/02/25更新 · NCT05908331Multi-Center Study of Clinical and Inflammatory Outcomes in Intensive Cardiac Rehabilitation and Traditional Cardiac Rehabilitation Programs
- Ballad CVA Heart Institute, Kingsport
被験者募集中
18歳以上 · 全性別 · 2024/05/21更新 · NCT06424119ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。